On 2025-02-14, Neuphoria Therapeutics Inc. (NEUP) announced earnings per share of $-1.23 for the fiscal quarter ending 2024-12-31, beating the average analyst estimate of $-2.01.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-02-14 | 2024-12-31 | $-2.01 | $-1.23 |